Focal hotspot and diffuse immune subtypes of tumor-infiltrating lymphocytes: AI-powered spatial clustering classification and its clinical relevance to HER2 expression in triple-negative breast cancer

This study distinguished focal hotspot and diffuse immune subtypes of TILs with distinct clinical implications in TNBC. The diffuse immune subtype correlated with enhanced NAC response and favorable prognosis, particularly in HER2-low TNBC. These findings highlighted the spatial immune architecture as a promising biomarker to refine treatment stratification and deepen our understanding of immune heterogeneity in HER2-low TNBC.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2025-12-23
DOI
https://doi.org/10.1186/s12967-025-07608-7
Citations
2
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
2.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Focal hotspot and diffuse immune subtypes of tumor-infiltrating lymphocytes: AI-powered spatial clustering classification and its clinical relevance to HER2 expression in triple-negative breast cancer

Bin Luo, Honglin Yan, H Zhang, Shuying Ai et al.
2 citations
Journal of Translational Medicine
Cancer Immunotherapy and Biomarkers
2.09
article

Focal hotspot and diffuse immune subtypes of tumor-infiltrating lymphocytes: AI-powered spatial clustering classification and its clinical relevance to HER2 expression in triple-negative breast cancer

Bin Luo, Honglin Yan, H Zhang, Shuying Ai, Jingping Yuan, Zhongtao Chen, Tian Jin, Chen Liu, Ting Xie, Shuaijun Chen
article en
2 citations

Abstract

This study distinguished focal hotspot and diffuse immune subtypes of TILs with distinct clinical implications in TNBC. The diffuse immune subtype correlated with enhanced NAC response and favorable prognosis, particularly in HER2-low TNBC. These findings highlighted the spatial immune architecture as a promising biomarker to refine treatment stratification and deepen our understanding of immune heterogeneity in HER2-low TNBC.

Journal of Translational MedicineVol. 24(1)
Wuhan University (CN), Klinikum Hanau (DE), Renmin Hospital of Wuhan University (CN), Central Hospital of Wuhan (CN)
Wuhan University, Renmin Hospital of Wuhan University
Good health and well-being
Openalex Percentile: Top 10%
Cancer Immunotherapy and Biomarkers
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.